Delivery Order SPE2DB22D1041-SPE2DB25FTZR9
Award Date
2/25/25
Potential Completion Date
2/26/25
Potential Value
$9.7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,773.34, is a delivery order for the supply of AMLOD-VALSA-HCTZ 10-320-25 MG 30S, a pharmaceutical product. The contract has an ultimate completion date of February 24, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,897.80 firm fixed-price delivery order covers the supply of AMLOD-VALSA-HCTZ 10-320-25 MG 30S, a medical product, with a completion date of December 26, 2023. This award is part of Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The $20,813.01 firm-fixed-price delivery order is for medical supplies, specifically AMLOD-VALSA-HCTZ 10-320-25 MG 30S. The contract has an ultimate completion date of May 9, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract, valued at $15,055.71, is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth $999,999,999. The IDC, which runs through November 2026, provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,321.05, is a firm fixed-price delivery order that has an ultimate completion date of November 7, 2024. The award is for the provision of AMLOD-VALSA-HCTZ 10-320-25 MG 30S pharmaceutical products. This contract is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,772.55, is a Firm Fixed Price Delivery Order with a completion date of February 3, 2025. The award covers the procurement of pharmaceutical products, including AMLOD-VALSA-HCTZ 10-320-25 MG 30S. This contract does not have a set-aside designation, indicating open competition. Amerisourcebergen...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA). The $2,590.80 firm fixed-price delivery order is for the supply of AMLOD-VALSA-HCTZ 10-160-25 MG 30S, a cardiovascular medication, to support military healthcare programs. The award is not associated with a set-aside designation. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,675.52, is a delivery order for the supply of AMLOD-VALSA-HCTZ 10-320-25 MG 30S medication. The contract does not have a set-aside designation, indicating it was an open competition. It is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,555.51, is a delivery order for AMLOD-VALSA-HCTZ 10-320-25 MG 30S, a medical commodity. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award, valued at $7,699.09, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order, with a firm fixed-price pricing type, and an ultimate completion date of January 2, 2025. The contract covers the procurement of AMLOD-VALSA-HCTZ 10-160-12.5MG tablets, a cardiovascular medication, to support military treatment facilities, veterans' healthcare...